Marengo Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$80M
- Investors
-
1
Marengo Therapeutics General Information
Description
Operator of a clinical-stage biotech company intended to tackle cancer with a novel mode of T-cell activation. The company uses a platform that activates T cell subsets consistently enriched in tumor-infiltrating lymphocytes (TILs) through co-stimulation of the TCR (t-cell receptor) and a secondary signal, enabling healthcare professionals to treat cancer and other diseases.
Contact Information
Website
www.marengotx.comCorporate Office
- 840 Memorial Drive
- 4th Floor
- Cambridge, MA 02139
- United States
Corporate Office
- 840 Memorial Drive
- 4th Floor
- Cambridge, MA 02139
- United States
Marengo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 08-Nov-2021 | $80M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 03-Jan-2018 | Completed | Startup |
Marengo Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Marengo Therapeutics Comparisons
Industry
Financing
Details
Marengo Therapeutics Competitors (115)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Adicet Bio | Formerly VC-backed | Boston, MA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| RootPath | Venture Capital-Backed | Watertown, MA | ||||
| ArsenalBio | Venture Capital-Backed | South San Francisco, CA |
Marengo Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Marengo Therapeutics Patents
Marengo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3242160-A1 | Multifuntional molecules binding to tcr and uses thereof | Pending | 22-Dec-2021 | ||
| GB-202409147-D0 | Multifuntional molecules binding to tcr and usees thereof | Pending | 22-Dec-2021 | ||
| AU-2022419371-A1 | Multifuntional molecules binding to tcr and uses thereof | Pending | 22-Dec-2021 | ||
| EP-4426321-A2 | Immune cell populations and uses thereof | Pending | 05-Nov-2021 | ||
| AU-2022255506-A1 | Multifunctional molecules binding to tcr and uses thereof | Pending | 08-Apr-2021 | C07K16/2809 |
Marengo Therapeutics Executive Team (12)
| Name | Title | Board Seat |
|---|---|---|
| Zhen Su MD | Chief Executive Officer & Board Member | |
| Svetlana Makhni | Chief Financial Officer | |
| Ke Liu Ph.D | Chief Development Officer | |
| Andrew Bayliffe Ph.D | Chief Scientific Officer & Board Member | |
| Kevin Chin MD | Chief Medical Officer |
Marengo Therapeutics Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrew Bayliffe Ph.D | Marengo Therapeutics | Chief Scientific Officer & Board Member | |
| Anna Batarina | Apple Tree Partners (ATP) | Board Member | |
| Joseph Yanchik III | Self | Board Member | |
| Rajesh Chopra Ph.D | Apple Tree Partners (ATP) | Board Member | |
| Seth Harrison MD | Apple Tree Partners (ATP) | Chairman |
Marengo Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Marengo Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apple Tree Partners (ATP) | Venture Capital | Minority |
Marengo Therapeutics FAQs
-
When was Marengo Therapeutics founded?
Marengo Therapeutics was founded in 2015.
-
Who is the founder of Marengo Therapeutics?
Andreas Loew Ph.D is the founder of Marengo Therapeutics.
-
Who is the CEO of Marengo Therapeutics?
Zhen Su MD is the CEO of Marengo Therapeutics.
-
Where is Marengo Therapeutics headquartered?
Marengo Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Marengo Therapeutics?
Marengo Therapeutics has 40 total employees.
-
What industry is Marengo Therapeutics in?
Marengo Therapeutics’s primary industry is Drug Discovery.
-
Is Marengo Therapeutics a private or public company?
Marengo Therapeutics is a Private company.
-
What is Marengo Therapeutics’s current revenue?
The current revenue for Marengo Therapeutics is .
-
How much funding has Marengo Therapeutics raised over time?
Marengo Therapeutics has raised $119M.
-
Who are Marengo Therapeutics’s investors?
Apple Tree Partners (ATP) has invested in Marengo Therapeutics.
-
Who are Marengo Therapeutics’s competitors?
NexImmune, Adicet Bio, Kite Pharma, RootPath, and ArsenalBio are some of the 115 competitors of Marengo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
